Efficacy and tolerability of hydrogen carbonate-rich water for heartburn
André-Michael Beer, Klinik Blankenstein, Ruhr-Universität Bochum, 45527 Hattingen, Germany
Ralf Uebelhack, Ute Pohl, Analyze and Realize GmbH, 13456 Berlin, Germany
Author contributions: Beer AM contributed to writing of the article; Uebelhack R was principal investigator and medical expert; Pohl U contributed to study conception and design, data acquisition as well as data analysis and interpretation; All authors contributed to editing, reviewing and final approval of the article.
Supported by Deutsche Heilbrunnen im Verband Deutscher Mineralbrunnen e. V., Kennedyallee 28, 53175 Bonn, Germany, www.vdm-bonn.de.
Institutional review board statement: The study protocol was approved by the relevant ethics committee [State Office of Health and Social Affairs Berlin (Landesamt für Gesundheit und Soziales Berlin)] and the competent authority [Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn)]. The presence of the approval document was verified by the editorial office. The document is available upon request.
Informed consent statement: Both the patients and the investigator signed the informed consent form before inclusion. The presence of the approval document was verified by the editorial office. The document is available upon request.
Conflict-of-interest statement: The preparation of the manuscript, and thus indirectly the authors Uebelkack R and Pohl U, were supported by Deutsche Heilbrunnen im Verband Deutscher Mineralbrunnen e. V., Kennedyallee 28, 53175 Bonn, Germany, www.vdm-bonn.de. The authors declare that besides this no conflict of interest exists.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dr. Ute Pohl, Analyze and Realize GmbH, Waldseeweg 6, 13456 Berlin, Germany. firstname.lastname@example.org
Telephone: +49-30-40008100 Fax: +49-30-40008100
Received: July 14, 2015
Peer-review started: July 17, 2015
First decision: August 31, 2015
Revised: November 17, 2015
Accepted: December 16, 2015
Article in press: December 18, 2015
Published online: February 15, 2016